3394.0 Controlling Methamphetamine Precursors: From Policy to Practice

Monday, November 5, 2007: 4:30 PM
Session Objectives: see session abstract

4:30 PM
4:44 PM
Legal approaches to addressing the public health threat of domestic methamphetamine production and use
Jean C. O'Connor, JD, MPH, Jamie F. Chriqui, PhD, MHS, Duane C. McBride, PhD, Shelby S. Eidson, JD and Carissa Baker
4:58 PM
"Meth labs have virtually dried up in our state": Impact and policy perspectives from state key informants
Curtis J. VanderWaal, MSW, PhD, Rachel M. Bishop, MSW, Duane C. McBride, PhD, Jamie F. Chriqui, PhD, MHS, Jean C. O'Connor, JD, MPH, Kimberly Rosales, MSW and Yvonne Terry-McElrath, MSA
5:12 PM
Prevalence and correlates of methamphetamine/amphetamine use among young adult injection drug users (IDUs) in five U.S. cities
Danielle C. Ompad, PhD, Mary H. Latka, PhD, Steffanie A. Strathdee, PhD, David W. Purcell, JD, PhD, Susan L. Bailey, Sharon M. Hudson, PhD, Hanne Thiede, DVM, MPH, Vijay Nandi, MPH and Richard S. Garfein, PhD, MPH
5:26 PM
Relationship between state precursor laws and methamphetamine small toxic lab seizures
Yvonne Terry-McElrath, MSA, Duane C. McBride, PhD, Jamie F. Chriqui, PhD, MHS, Jean C. O'Connor, JD, MPH and Curtis J. VanderWaal, MSW, PhD

See individual abstracts for presenting author's disclosure statement and author's information.

Organized by: Alcohol, Tobacco, and Other Drugs

CE Credits: CME, Health Education (CHES), Nursing